Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q1 EPS of ($0.41). Revenue for the quarter came in at $5 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.